These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31909673)

  • 41. Are we aware of ecstasy effects?
    Gritti P; Agostinis C; Bortolotti GM; Zilio A
    Intern Emerg Med; 2009 Apr; 4(2):175-7. PubMed ID: 19030950
    [No Abstract]   [Full Text] [Related]  

  • 42. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL; Shear PK; Corcoran K
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC; Parrott AC; Turner JJ
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Motor delays in MDMA (ecstasy) exposed infants persist to 2 years.
    Singer LT; Moore DG; Min MO; Goodwin J; Turner JJ; Fulton S; Parrott AC
    Neurotoxicol Teratol; 2016; 54():22-8. PubMed ID: 26806601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.
    Silins E; Copeland J; Dillon P
    Aust N Z J Psychiatry; 2007 Aug; 41(8):649-55. PubMed ID: 17620161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ecstasy use and self-reported disturbances in sleep.
    Ogeil RP; Rajaratnam SM; Phillips JG; Redman JR; Broadbear JH
    Hum Psychopharmacol; 2011 Oct; 26(7):508-16. PubMed ID: 21953704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
    Kish SJ
    Pharmacol Biochem Behav; 2002 Apr; 71(4):845-55. PubMed ID: 11888575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring synthetic drug markets, trends, and public health.
    Spruit IP
    Subst Use Misuse; 2001 Jan; 36(1-2):23-47. PubMed ID: 11305353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA.
    Palamar JJ
    J Psychoactive Drugs; 2018; 50(1):88-93. PubMed ID: 28937933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma amino acids in ecstasy users.
    Stuerenburg HJ; Petersen K; Buhmann C; Rosenkranz M; Baeumer T; Thomasius R
    Neuro Endocrinol Lett; 2003 Oct; 24(5):348-9. PubMed ID: 14647011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ecstasy toxicity].
    Reingardiene D
    Medicina (Kaunas); 2006; 42(6):519-23. PubMed ID: 16816548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ecstasy: as harmful as heroin?
    Scott R
    J Law Med; 2009 Dec; 17(3):327-48. PubMed ID: 20169795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Toxicity of ecstasy].
    Mas M; Farré M; Roset PN; Camí J
    Med Clin (Barc); 1998 Oct; 111(13):516-7. PubMed ID: 9859071
    [No Abstract]   [Full Text] [Related]  

  • 58. [Drunkenness, driving and sexual relations in young cocaine and ecstasy users].
    Becoña Iglesias E; López-Durán A; Fernández Del Río E; Martínez Pradeda Ú; Osorio López J; Fraga Ares J; Arrojo Romero M; López Crecente F; Domínguez González MN
    Adicciones; 2011; 23(3):205-18. PubMed ID: 21814709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The rise of new psychoactive substance use in Australia.
    Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
    Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ecstasy (MDMA) and oral health.
    Brand HS; Dun SN; Nieuw Amerongen AV
    Br Dent J; 2008 Jan; 204(2):77-81. PubMed ID: 18268544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.